Transcript Open slides - CTN Dissemination Library

Mt. Hood
IOM Report:
10 Years After & More Coming
Mitch Greenlick, Ph.D.
Oregon State Representative
April 21, 2010
Bridging the Gap Between
Practice and Research:
Forging Partnerships with Community-Based
Drug and Alcohol Treatment
Sara Lamb, Merwyn Greenlick, and Dennis
McCarty, Editors
Institute of Medicine
1998
Findings and Recommendations

Strategies for:
– Linking research and practice
– Linking research findings, policy development,
–
–
–
–
and treatment implementation
Knowledge development
Dissemination and knowledge transfer
Consumer participation
Training for consumer-based research
collaboration
The First Recommendation

The National Institute on Drug Abuse and
the Center for Substance Abuse Treatment
should support the development of an
infrastructure to facilitate research within
a network of community-based treatment
programs.
The Second Recommendation

The National Institute on Drug Abuse and
the National Institute on Alcohol Abuse
should develop research initiatives to foster
studies that include community-based
treatment programs as full partners.
Issues Raised by
Recommendation 2

Include treatment staff in the development of
research initiatives and review of proposals
 Require assessment of burden of proposed
research on treatment program and subjects
 Assess relevance and practicality for CBO
implementation of proposed research
 Require active, early, and permanent participation
of treatment staff in the development,
implementation, and interpretation of research
studies.
What Does the Future Hold

Translational research: bench to bedside to
community
 Community-participatory research
 Increased demand for evidenced-based
practices by policy makers
 Comparative effectiveness research
 Increased recognition of the social costs of
substance abuse.
Translational Research

To improve human health, scientific
discoveries must be translated into practical
applications. Such discoveries typically
begin at “the bench” with basic research —
in which scientists study disease at a
molecular or cellular level — then progress
to the clinical level, or the patient's
“bedside.”
Comparative Effectiveness
Research

Comparative effectiveness research is
designed to inform health-care decisions by
providing evidence on the effectiveness,
benefits, and harms of different treatment
options. The evidence is generated from
research studies that compare drugs,
medical devices, tests, surgeries, or ways to
deliver health care
Steps Involved in Comparative
Effectiveness Research







Identify new and emerging clinical interventions.
Review and synthesize current medical research.
Identify gaps between existing medical research
and the needs of clinical practice.
Promote and generate new scientific evidence and
analytic tools.
Train and develop clinical researchers.
Translate and disseminate research findings to
diverse stakeholders.
Reach out to stakeholders via a citizens forum.
Elements of the CTN Produce
Perfect Setting to Move Forward

Community participation in research
 Multicenter controlled-trial approach
 Potential for comparative effectiveness
research
 Ability to move into policy transformation
 Trained researchers and research-trained
treatment personal